Point72 Hong Kong’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-216
Closed -$3K 1236
2022
Q3
$3K Buy
+216
New +$3.73K ﹤0.01% 1833
2022
Q2
Sell
-103
Closed -$2K 2296
2022
Q1
$2K Buy
+103
New +$2.08K ﹤0.01% 1734
2020
Q2
Sell
-184
Closed -$4K 1354
2020
Q1
$4K Buy
+184
New +$4.5K ﹤0.01% 805
2019
Q3
Sell
-421
Closed -$13K 1253
2019
Q2
$13K Buy
+421
New +$13.2K ﹤0.01% 838
2019
Q1
Sell
-32
Closed -$1K 1213
2018
Q4
$1K Sell
32
-8
-20% -$302 ﹤0.01% 809
2018
Q3
$2K Sell
40
-15
-27% -$709 ﹤0.01% 782
2018
Q2
$3K Buy
+55
New +$2.44K ﹤0.01% 751

Other funds holding PAHC

Point72 Hong Kong's PAHC Position: Q4 2022 in Review

Point72 Hong Kong sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 216 shares — an estimated $3K sold.

Point72 Hong Kong first reported a position in PAHC in Q2 2018 and held it in 7 quarters. The position peaked at $13K in Q2 2019. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

  • Point72 Hong Kong reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 216 Phibro Animal Health shares in Q4 2022, an estimated $3K.
  • Point72 Hong Kong first reported a position in Phibro Animal Health in Q2 2018 and held it in 7 quarters.
  • Point72 Hong Kong's Phibro Animal Health position peaked at $13K in Q2 2019.
  • 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.